Sonoma Pharmaceuticals, Inc. (SNOA)

Sonoma Pharmaceuticals Revenue

In the fiscal year ending March 31, 2024, Sonoma Pharmaceuticals had annual revenue of $12.74M. Revenue in the quarter ending March 31, 2024 was $3.44M with 14.10% year-over-year growth.

• Revenue (ttm): $12.74M
• Revenue Growth: -4.05%
• P/S Ratio: 0.46
• Revenue / Employee: $1,273,500
• Employees: 10
• Market Cap: 5.85M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	12.74M	-537.00K	-4.05%
Mar 31, 2023	13.27M	644.00K	5.10%
Mar 31, 2022	12.63M	-6.00M	-32.21%
Mar 31, 2021	18.63M	701.00K	3.91%
Mar 31, 2020	17.93M	-1.04M	-5.49%
Mar 31, 2019	18.97M	2.31M	13.88%
Mar 31, 2018	16.66M	3.83M	29.89%
Mar 31, 2017	12.83M	3.46M	36.89%
Mar 31, 2016	9.37M	-4.49M	-32.37%
Mar 31, 2015	13.85M	186.00K	1.36%
Mar 31, 2014	13.67M	-1.78M	-11.55%
Mar 31, 2013	15.45M	2.71M	21.25%
Mar 31, 2012	12.74M	2.99M	30.65%
Mar 31, 2011	9.75M	2.39M	32.46%
Mar 31, 2010	7.36M	1.98M	36.67%
Mar 31, 2009	5.39M	1.55M	40.50%
Mar 31, 2008	3.84M	-708.00K	-15.58%
Mar 31, 2007	4.54M	1.96M	75.81%
Mar 31, 2006	2.58M	1.23M	90.56%
Mar 31, 2005	1.36M	454.00K	50.33%
Mar 31, 2004	902.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.